Beqvez
Payments companies reported to CMS as associated with Beqvez. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Beqvez, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Beqvez
These are the largest totals companies reported as associated with Beqvez. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kuchikala Reddy | Philadelphia, PA | Gastroenterology (Internal Medicine) | $6,750.00 |
| Nathan Connell | Boston, MA | Hematology (Internal Medicine) | $2,500.00 |
| Maya Bloomberg | Miami, FL | Nurse Practitioner | $2,070.00 |
| Benjamin Samelson Jones | Philadephia, PA | Pediatric Hematology-Oncology | $2,063.51 |
| Barbara Konkle | Seattle, WA | Hematology (Internal Medicine) | $2,033.36 |
| Guy Young | Bozeman, MT | Pediatric Hematology-Oncology | $2,032.20 |
| Steven Pipe | Ann Arbor, MI | Pediatric Hematology-Oncology | $2,000.00 |
| Ype De Jong | New York, NY | Gastroenterology (Internal Medicine) | $2,000.00 |
| Adam Cuker | Philadelphia, PA | Hematology (Internal Medicine) | $2,000.00 |
| Andrew Leavitt | San Francisco, CA | Hematology (Internal Medicine) | $2,000.00 |
Prescribed Beqvez?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.